ES2104720T3 - Diagnosticos del virus de la hepatitis no-a, no-b (nanbv) polinucleotidos utiles para escrutar el virus de la hepatitis c. - Google Patents

Diagnosticos del virus de la hepatitis no-a, no-b (nanbv) polinucleotidos utiles para escrutar el virus de la hepatitis c.

Info

Publication number
ES2104720T3
ES2104720T3 ES91916041T ES91916041T ES2104720T3 ES 2104720 T3 ES2104720 T3 ES 2104720T3 ES 91916041 T ES91916041 T ES 91916041T ES 91916041 T ES91916041 T ES 91916041T ES 2104720 T3 ES2104720 T3 ES 2104720T3
Authority
ES
Spain
Prior art keywords
hepatitis
virus
scrutining
nanbv
diagnoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91916041T
Other languages
English (en)
Other versions
ES2104720T4 (es
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Amy J Weiner
Jang Han
Michael Steven Urdea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ES2104720T3 publication Critical patent/ES2104720T3/es
Publication of ES2104720T4 publication Critical patent/ES2104720T4/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN NUEVO VIRUS, VIRUS DE LA HEPATITIS C (HCV), QUE HA RESULTADO SER EL MAYOR AGENTE ETIOLOGICO DE TRASTORNOS SANGUINEOS DE NACIMIENTO NANBH, FUE DESCUBIERTO POR APPLICANT. SE HAN PROPORCIONADO REACTIVOS PARA AISLAR, AMPLIFICAR Y DETECTAR HCV POLINUCLEOTIDOS. ESTOS AGENTES SON OLIGOMEROS COMPRENDIDOS POR SECUENCIAS DE POLINUCLEOTIDOS QUE SON CAPACES DE FORMAR ESTRUCTURAS HIBRIDAS CONSECUENCIAS DE POLINUCLEOTIDOS DE BLANCOS HCV.
ES91916041T 1990-08-10 1991-08-12 Diagnosticos del virus de la hepatitis no-a, no-b (nanbv): polinucleotidos utiles para escrutar el virus de la hepatitis c. Expired - Lifetime ES2104720T4 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56620990A 1990-08-10 1990-08-10

Publications (2)

Publication Number Publication Date
ES2104720T3 true ES2104720T3 (es) 1997-10-16
ES2104720T4 ES2104720T4 (es) 1997-12-16

Family

ID=24261960

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91916041T Expired - Lifetime ES2104720T4 (es) 1990-08-10 1991-08-12 Diagnosticos del virus de la hepatitis no-a, no-b (nanbv): polinucleotidos utiles para escrutar el virus de la hepatitis c.

Country Status (19)

Country Link
EP (1) EP0543924B1 (es)
JP (1) JP2714255B2 (es)
KR (1) KR0163964B1 (es)
AT (1) ATE154646T1 (es)
AU (1) AU660940B2 (es)
BG (1) BG61615B1 (es)
CA (1) CA2089080C (es)
CZ (1) CZ282573B6 (es)
DE (1) DE69126617T2 (es)
DK (1) DK0543924T3 (es)
ES (1) ES2104720T4 (es)
FI (1) FI106214B (es)
GR (1) GR3024480T3 (es)
HU (2) HUT69140A (es)
NO (1) NO308621B1 (es)
PL (1) PL169035B1 (es)
RO (1) RO109952B1 (es)
RU (1) RU2180354C2 (es)
WO (1) WO1992002642A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571554A1 (en) * 1991-01-14 1993-12-01 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
ES2188583T3 (es) 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
ES2111589T3 (es) * 1991-08-27 1998-03-16 Hoffmann La Roche Metodos y reactivos para la deteccion de la hepatitis c.
EP0532258A2 (en) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
EP0610436B9 (en) 1991-11-21 2003-03-26 Common Services Agency Hepatitis-c virus testing
CA2136764A1 (en) * 1992-05-29 1993-12-09 Ronald L. Marshall Ligase chain reaction starting with rna sequences
JPH0670800A (ja) * 1992-08-26 1994-03-15 Imuno Japan:Kk Ｈｃｖゲノムの多様性検出方法、プライマー
WO1994005813A1 (en) * 1992-09-10 1994-03-17 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Compositions and methods for treatment of hepatitis c virus-associated diseases
DE69324678T2 (de) 1992-11-27 1999-12-09 Naamloze Vennootschap Innogenetics S.A., Gent Verfahren zur typisierung von hcv-isolaten
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20030180814A1 (en) * 2002-03-21 2003-09-25 Alastair Hodges Direct immunosensor assay
EP2163651A1 (en) * 2002-07-26 2010-03-17 Abbott Laboratories Method of detecting and quantifying hepatitis C virus
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
CA2618429A1 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
JP2696116B2 (ja) * 1988-09-30 1998-01-14 財団法人阪大微生物病研究会 非ａ非ｂ肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするｄｎａ
CA2046919A1 (en) * 1989-02-14 1990-08-15 Mark P. Pasek Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
ATE211772T1 (de) * 1989-05-18 2002-01-15 Chiron Corp Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus
SU1742331A1 (ru) * 1989-08-10 1992-06-23 Институт Органического Синтеза Ан Латвсср Рекомбинантна плазмидна ДНК @ BLV 51-3, кодирующа кор-антиген вируса гепатита В с экспонированным на его поверхности эпитопом BLV @ 51 (56-103), вируса лейкоза крупного рогатого скота способ ее конструировани и штамм бактерий ЕSснеRIснIа coLI - продуцент кор-антигена вируса гепатита В с экспонированным на его поверхности эпитопом BLV @ 51 (56-103)
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
DE69125066T2 (de) * 1990-07-11 1997-09-25 Shionogi Seiyaku K K Trading U cDNS-Sequenz und Detektion des Hepatitis C-Virus

Also Published As

Publication number Publication date
CZ282573B6 (cs) 1997-08-13
HU9300323D0 (en) 1993-05-28
DK0543924T3 (da) 1997-09-08
CZ16793A3 (en) 1993-05-12
HU227499B1 (en) 2011-07-28
EP0543924B1 (en) 1997-06-18
FI930582L (fi) 1993-04-07
KR0163964B1 (ko) 1998-11-16
WO1992002642A1 (en) 1992-02-20
JPH06503707A (ja) 1994-04-28
AU660940B2 (en) 1995-07-13
AU8509991A (en) 1992-03-02
NO930429D0 (no) 1993-02-08
EP0543924A1 (en) 1993-06-02
DE69126617D1 (de) 1997-07-24
RO109952B1 (ro) 1995-07-28
GR3024480T3 (en) 1997-11-28
ES2104720T4 (es) 1997-12-16
BG97435A (bg) 1994-03-24
FI106214B (fi) 2000-12-15
DE69126617T2 (de) 1997-10-02
EP0543924A4 (en) 1993-07-21
JP2714255B2 (ja) 1998-02-16
RU2180354C2 (ru) 2002-03-10
PL169035B1 (pl) 1996-05-31
HUT69140A (en) 1995-08-28
BG61615B1 (bg) 1998-01-30
CA2089080A1 (en) 1992-02-11
FI930582A0 (fi) 1993-02-10
NO930429L (no) 1993-04-05
ATE154646T1 (de) 1997-07-15
NO308621B1 (no) 2000-10-02
CA2089080C (en) 2007-04-03

Similar Documents

Publication Publication Date Title
ES2104720T3 (es) Diagnosticos del virus de la hepatitis no-a, no-b (nanbv) polinucleotidos utiles para escrutar el virus de la hepatitis c.
ES2166749T3 (es) Diagnosticos de nanbv: polinucleotidos utiles para discriminar virus de la hepatitis c.
ES2012739T5 (es) Diagnosticos para nanbv.
ES2176342T3 (es) Secuencias del genotipo 7 del virus de la hepatitis c y su utilizacioncomo agentes profilacticos, terapeuticos y de diagnostico.
ATE473750T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der unterdrückung von hepatitis virus infektion
ES2107609T3 (es) Polipeptidos sinteticos como inhibidores de vih-1.
MX9202783A (es) Hepatitis c diagnostico y vacuna.
DE69330372D1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
CY1110437T1 (el) Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c
ES2055922T3 (es) Vacunas para la proteccion ante infecciones por virus hiv, procedimiento para su preparacion y su uso como agente de diagnostico e inmunoterapeutico.
ES2054696T3 (es) Agente viral de la hepatitis nanb, antigen y reactivo inmunologico.
AR041964A1 (es) Vacuna de vhc que comprende un polinucleotido
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
ES2061506T3 (es) Oxazolidinonas fluoroquimicas.
ES2286212T3 (es) Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
Chen et al. Hepatitis C virus infection in Taiwan
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
ES2146574T3 (es) Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.
ES2058116T3 (es) El virus varicella-zoster como una vacuna recombinante viva.
ES2060650T3 (es) Peptidos de rinovirus humanos.
ES2042481T1 (es) Peptidos sinteticos que derivan del antigeno hbc del virus de la hepatitis b.
ES2056028B1 (es) Procedimiento para la seleccion de oligonucleotidos para la amplificacion especifica de genomas altamente variables.
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 543924

Country of ref document: ES